Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Apostolia M Tsimberidou

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Nature Reviews. Clinical Oncology|March 22, 2016
Health policy: Strategies to optimize expedited investigational new drug safety reportsApostolia M Tsimberidou
The Lancet. Oncology|December 19, 2015
Precision medicine: lessons learned from the SHIVA trialApostolia M Tsimberidou, Razelle Kurzrock
Future Oncology (London, England)|July 23, 2015
Left ventricular ejection fraction in advanced cancer patients: a valuable prognostic tool?Rabih Said, Apostolia M Tsimberidou
Expert Review of Clinical Pharmacology|July 26, 2018
Overview of precision oncology trials: challenges and opportunitiesElena Fountzilas, Apostolia M Tsimberidou
Expert Opinion on Biological Therapy|September 13, 2017
Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disordersRabih Said, Apostolia M Tsimberidou
Hematological Oncology|April 3, 2008
Relevance of clinical trials in acute myeloid leukaemiaApostolia M Tsimberidou, Elihu Estey
Therapeutics and Clinical Risk Management|June 19, 2009
Dasatinib in chronic myeloid leukemia: a reviewDolly G Aguilera, Apostolia M Tsimberidou
Cancer Chemotherapy and Pharmacology|March 7, 2013
Anti-vascular endothelial growth factor therapy in the era of personalized medicineLuis R Féliz, Apostolia M Tsimberidou
Expert Opinion on Investigational Drugs|January 23, 2018
Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefitsElena Fountzilas, Rabih Said, Apostolia M Tsimberidou
Seminars in Cancer Biology|October 6, 2020
Innovative trial design in precision oncologyApostolia M Tsimberidou, Peter Müller, Yuan Ji
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Nature Reviews. Clinical Oncology|March 22, 2016
Health policy: Strategies to optimize expedited investigational new drug safety reportsApostolia M Tsimberidou
The Lancet. Oncology|December 19, 2015
Precision medicine: lessons learned from the SHIVA trialApostolia M Tsimberidou, Razelle Kurzrock
Future Oncology (London, England)|July 23, 2015
Left ventricular ejection fraction in advanced cancer patients: a valuable prognostic tool?Rabih Said, Apostolia M Tsimberidou
Expert Review of Clinical Pharmacology|July 26, 2018
Overview of precision oncology trials: challenges and opportunitiesElena Fountzilas, Apostolia M Tsimberidou
Expert Opinion on Biological Therapy|September 13, 2017
Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disordersRabih Said, Apostolia M Tsimberidou
Hematological Oncology|April 3, 2008
Relevance of clinical trials in acute myeloid leukaemiaApostolia M Tsimberidou, Elihu Estey
Therapeutics and Clinical Risk Management|June 19, 2009
Dasatinib in chronic myeloid leukemia: a reviewDolly G Aguilera, Apostolia M Tsimberidou
Cancer Chemotherapy and Pharmacology|March 7, 2013
Anti-vascular endothelial growth factor therapy in the era of personalized medicineLuis R Féliz, Apostolia M Tsimberidou
Expert Opinion on Investigational Drugs|January 23, 2018
Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefitsElena Fountzilas, Rabih Said, Apostolia M Tsimberidou
Seminars in Cancer Biology|October 6, 2020
Innovative trial design in precision oncologyApostolia M Tsimberidou, Peter Müller, Yuan Ji
Pageof 21